Integrated Research (IRI.AX) Akcija Kursas
Integrated Research Kursas
Per pastaruosius 19 metus Integrated Research pajamos augo 2,5 % kasmet ir pasiekė 57,64 mln. AUD. Pelnas akcijai mažėjo 8,0 % per metus per pastaruosius 19 metus. Integrated Research grynoji marža 2,1 % yra iš esmės stabili palyginti su 2,5 % prieš kelerius metus. Esama kaina dividendo pajamingumas yra apie 10,78 %. Išmokų koeficientas yra apie 29 % pelno. Integrated Research 12 mėn. konsensuso tikslinė kaina yra 0,41 AUD, apie virš kursą 54,0 %. Iš 5 analitikų 4 rekomenduoja pirkti — bendras konsensusas yra Pirkti.
Integrated Research akcijos kaina
Gaukite šiuos duomenis per Eulerpool API
100 000 užklausų/mėn. nemokamai · be kortelės
Integrated Research akcija ir akcijų analizė
Dažnai užduodami klausimai apie Integrated Research akciją
Integrated Research Ltd (IRL) is an Australian-based software company specializing in performance management and critical business communication solutions. IRL's business model revolves around developing and delivering innovative software solutions that help organizations optimize and manage their critical IT infrastructure, communications, and payments. By offering a comprehensive suite of products, including Prognosis, IR Collaborate, and Payments Notification, IRL enables businesses to proactively monitor, measure, and enhance the performance of their mission-critical systems and applications. IRL's business model focuses on providing reliable and effective solutions that drive operational efficiency, increase customer satisfaction, and ensure smooth, uninterrupted business operations.
Integrated Research Ltd (IR) is primarily active in the software and technology industry. As a global provider of proactive performance management software, IR serves various sectors including banking and financial services, telecommunications, government, and healthcare. With its innovative solutions, IR helps organizations enhance their operational efficiency, resolve critical system issues, and maintain optimal performance across their networks.
Integrated Research Ltd faces competition from multiple companies in the market. Some of its main competitors include NICE Ltd, Verint Systems Inc, and CA Technologies. These companies also offer software solutions and services for business performance, customer experience management, and collaboration. Integrated Research differentiates itself through its innovative and comprehensive approach to monitoring and managing critical IT infrastructure and applications. With its strong market presence and reputation in the industry, Integrated Research continues to face competition but remains a leading player in the market.
Integrated Research Ltd is an Australian company that specializes in developing and providing performance management software solutions. Founded in 1988, Integrated Research has grown to become a leading global provider of monitoring, diagnostics, and business process automation solutions. The company's flagship product, Prognosis, offers real-time insights into critical IT infrastructure and business processes, allowing organizations to optimize performance, enhance customer experiences, and improve operational efficiency. With a strong focus on innovation and strategic partnerships, Integrated Research continues to expand its global presence and deliver cutting-edge solutions to help businesses across various industries achieve their performance goals.
Some significant milestones achieved by Integrated Research Ltd include becoming a publicly listed company on the Australian Stock Exchange in 2000, expanding its global presence with offices in North America, Europe, and Asia, and consistently delivering strong financial performance with steady revenue growth. The company has also forged strategic partnerships with major technology providers, enabling it to develop innovative and industry-leading solutions. Integrated Research Ltd has received multiple prestigious industry awards, acknowledging its commitment to delivering excellence in performance management and monitoring solutions for business-critical environments. These achievements demonstrate the company's continuous growth, market recognition, and dedication to providing cutting-edge solutions for its clients.
Integrated Research Ltd is primarily present in various countries and regions around the world. The company's presence can be found in Australia, North America, Europe, Asia-Pacific, and Latin America. With a global footprint, Integrated Research Ltd has established a strong presence in these regions, delivering its innovative solutions and services to customers worldwide.
Integrated Research Ltd represents a strong commitment to innovation, excellence, and customer satisfaction. The company's corporate philosophy centers around delivering world-class software solutions and services that empower businesses to optimize their performance and ensure superior customer experiences. Integrated Research Ltd focuses on leveraging cutting-edge technologies and industry expertise to deliver actionable insights and intelligent automation. With a customer-centric approach, the company aims to build long-term partnerships and provide comprehensive support to meet the unique needs of its clients. In essence, Integrated Research Ltd stands for a dedication to success, leadership in technology, and delivering value to its stakeholders.
Analitikai šiuo metu nustato vidutinę Integrated Research akcijos tikslinę kainą 0,41 AUD (mediana: 0,41 AUD), t. y. +48,4 % palyginti su paskutine kaina. Konsensusas pagrįstas 5 analitikų reitingais.
5 analitikai šiuo metu vertina Integrated Research akciją: 4 rekomenduoja pirkti, 1 laikyti ir 0 parduoti.
Pagal dabartinį kursą Integrated Research akcija kainuoja 0,16 EUR (0,26 AUD).
Integrated Research akcija (IRI.AX) kotiruojama 2 biržose, įskaitant: ASX (IRI.AX).
Integrated Research Ltd is an IT company specializing in monitoring and managing business applications to ensure smooth business operations. Founded in 1988 and headquartered in Sydney, Australia, Integrated Research Ltd offers a wide range of solutions for IT infrastructure, communication, and collaboration for businesses. Its business model is based on three main divisions: forecasting and performance analytics, unified communications monitoring, and network management. Each division offers different products and services to help companies effectively manage their IT infrastructure. Overall, Integrated Research Ltd aims to support companies in effectively managing their IT infrastructure and ensuring seamless business operations.
pelnas Integrated Research yra 57,64 mln. AUD. Šis skaičius grindžiamas dabartiniais finansiniais duomenimis ir atspindi įmonės verslo rezultatus.
grynasis pelnas Integrated Research yra 1,21 mln. AUD. Grynasis pelnas atspindi įmonės pelningumą po visų išlaidų atimties.
Kainų ir nuomos santykis (KGV) Integrated Research šiuo metu yra 39,51. KGV lygina dabartinę akcijos kainą su pelnu už akciją ir padeda investuotojams įvertinti Integrated Research akcijos vertę.
Kainų ir pardavimų santykis (KUV) Integrated Research šiuo metu yra 0,83. KUV lygina rinkos kapitalizaciją su metinėmis pajamomis ir yra Integrated Research akcijos įvertinimo metrika.
Eulerpool kokybės balas Integrated Research yra 1/10.
Integrated Research ISIN yra AU000000IRI3. ISIN (International Securities Identification Number) yra pasaulinė unikali vertybinių popierių identifikacijos sistema.
Integrated Research prekybos žymė yra IRI.AX. Ši biržos žymė naudojama Integrated Research akcijoms prekiauti biržoje.
Integrated Research akcija
Integrated Research Pagrindiniai konkurentai
Integrated Research Biržos simbolis
Integrated Research FIGI
Visos Integrated Research pagrindinės charakteristikos ir giluminė analizė
Mūsų akcijų analizė Integrated Research akcijai apima svarbius finansinius rodiklius, tokius kaip apyvarta, pelnas, P/E santykis, P/S santykis, EBIT, taip pat informaciją apie dividendes. Be to, mes nagrinėjame aspektus, tokius kaip akcijos, rinkos kapitalizacija, skolos, nuosavas kapitalas ir įsipareigojimai Integrated Research. Jei ieškote išsamesnės informacijos šiais klausimais, mūsų poskyriuose galite rasti išsamias analizes: